Published in Muscle Nerve on February 01, 2012
Electrodiagnosis in persons with amyotrophic lateral sclerosis. PM R (2013) 0.85
Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol (2016) 0.82
Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Neurotherapeutics (2015) 0.81
Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease. Neurotherapeutics (2016) 0.79
Does Awaji decrease diagnostic yield in ALS? Muscle Nerve (2012) 0.77
The Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese population. PLoS One (2017) 0.75
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol (2002) 3.00
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.33
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med (2009) 2.25
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet (2008) 2.21
Supplementary motor area stimulation for Parkinson disease: a randomized controlled study. Neurology (2013) 2.12
Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet (2008) 2.09
Reference values for voluntary and stimulated single-fibre EMG using concentric needle electrodes: a multicentre prospective study. Clin Neurophysiol (2011) 2.08
New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: a clinical review. Clin Neurophysiol (2013) 2.05
The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol (2007) 2.05
Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol (2009) 2.00
Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n. Am J Hum Genet (2009) 1.96
Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med (2009) 1.96
A patient with familial amyotrophic lateral sclerosis associated with a new valosin-containing protein (VCP) gene mutation. Rinsho Shinkeigaku (2015) 1.94
Appropriate data cleaning methods for genome-wide association study. J Hum Genet (2008) 1.92
Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2. J Neurosci (2010) 1.91
CAG repeat disorder models and human neuropathology: similarities and differences. Acta Neuropathol (2007) 1.86
Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology (2014) 1.82
Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann Neurol (2012) 1.76
SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol (2004) 1.72
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol (2005) 1.64
Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling. Genes Dev (2004) 1.63
Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J (2004) 1.57
Task-guided selection of the dual neural pathways for reading. Neuron (2006) 1.55
A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants. Ann Neurol (2012) 1.55
Magnetic stimulation of the sacral roots for the treatment of urinary frequency and urge incontinence: an investigational study and placebo controlled trial. J Urol (2002) 1.54
Consensus paper: combining transcranial stimulation with neuroimaging. Brain Stimul (2009) 1.54
Motor dominant neuropathy in Sjögren's syndrome: report of two cases. Intern Med (2002) 1.50
Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. Am J Pathol (2003) 1.49
Expression of human Gaucher disease gene GBA generates neurodevelopmental defects and ER stress in Drosophila eye. PLoS One (2013) 1.45
Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann Neurol (2004) 1.45
Anti-NMDA receptor encephalitis associated with transient cerebral dyschromatopsia, prosopagnosia, and lack of stereopsis. J Neuroophthalmol (2014) 1.42
A case of atypical amyloid polyneuropathy with predominant upper-limb involvement with the diagnosis unexpectedly found at lung operation. Intern Med (2010) 1.40
Somatosensory evoked potential recovery in kii amyotrophic lateral sclerosis/parkinsonism-dementia complex (kii AlS/PDC). Clin Neurophysiol (2003) 1.40
Spread to the dorsal ulnar cutaneous branch: a pitfall during the routine antidromic sensory nerve conduction study of the ulnar nerve. Clin Neurophysiol (2011) 1.39
Impaired cardiovascular autonomic function in Parkinson's disease with visual hallucinations. Mov Disord (2007) 1.39
Bidirectional long-term motor cortical plasticity and metaplasticity induced by quadripulse transcranial magnetic stimulation. J Physiol (2008) 1.38
Segmental evaluation of the peripheral nerve using tibial nerve SEPs for the diagnosis of CIDP. Clin Neurophysiol (2009) 1.37
Mechanisms of intracortical I-wave facilitation elicited with paired-pulse magnetic stimulation in humans. J Physiol (2002) 1.36
Isolated shoulder paresis caused by a small cortical infarction. Neurology (2003) 1.35
A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. BMC Med Genet (2010) 1.35
CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS One (2010) 1.34
Basic mechanisms of TMS. J Clin Neurophysiol (2002) 1.34
Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Invest (2012) 1.32
Multiplex families with multiple system atrophy. Arch Neurol (2007) 1.32
Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J Hepatol (2011) 1.30
C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Arch Neurol (2012) 1.29
Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development. Hum Mol Genet (2003) 1.27
Intranuclear degradation of polyglutamine aggregates by the ubiquitin-proteasome system. J Biol Chem (2009) 1.26
Abeta42 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate. J Biol Chem (2007) 1.26
Short and long duration transcranial direct current stimulation (tDCS) over the human hand motor area. Exp Brain Res (2007) 1.26
SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians. PLoS One (2013) 1.23
A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55). J Med Genet (2012) 1.22
Dominant mutations in RP1L1 are responsible for occult macular dystrophy. Am J Hum Genet (2010) 1.21
Small saccades restrict visual scanning area in Parkinson's disease. Mov Disord (2011) 1.21
Dissociated small hand muscle atrophy in amyotrophic lateral sclerosis: frequency, extent, and specificity. Muscle Nerve (2008) 1.16
Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol (2008) 1.15
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. Hum Mol Genet (2003) 1.14
Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol Dis (2011) 1.13
A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations. Mov Disord (2009) 1.12
Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics (2009) 1.12
0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease. Mov Disord (2003) 1.11
Consensus: New methodologies for brain stimulation. Brain Stimul (2008) 1.10
Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation. Am J Hum Genet (2011) 1.10
Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am J Hum Genet (2010) 1.10
Reply to "Reference values in concentric needle electrode studies". Clin Neurophysiol (2012) 1.10
Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. Arch Neurol (2003) 1.08
Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients. PLoS One (2013) 1.06
Effects of 1-Hz repetitive transcranial magnetic stimulation on acute pain induced by capsaicin. Pain (2004) 1.06
Determination of editors at the novel A-to-I editing positions. Neurosci Res (2008) 1.06
IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur J Immunol (2007) 1.05
Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000. J Neurol Sci (2004) 1.05
Comparison of different methods for estimating motor threshold with transcranial magnetic stimulation. Clin Neurophysiol (2007) 1.05
CADASIL and CARASIL. Brain Pathol (2014) 1.05
Effective connectivity between human supplementary motor area and primary motor cortex: a paired-coil TMS study. Exp Brain Res (2012) 1.04
Comparison between short train, monophasic and biphasic repetitive transcranial magnetic stimulation (rTMS) of the human motor cortex. Clin Neurophysiol (2004) 1.04
Genotype-phenotype correlations in early onset ataxia with ocular motor apraxia and hypoalbuminaemia. Brain (2011) 1.04
Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide. Pediatr Cardiol (2011) 1.04
High-frequency rTMS over the supplementary motor area for treatment of Parkinson's disease. Mov Disord (2008) 1.03
The FHA domain of aprataxin interacts with the C-terminal region of XRCC1. Biochem Biophys Res Commun (2004) 1.03
Initiation and inhibitory control of saccades with the progression of Parkinson's disease - changes in three major drives converging on the superior colliculus. Neuropsychologia (2011) 1.02
Aprataxin, the causative protein for EAOH is a nuclear protein with a potential role as a DNA repair protein. Ann Neurol (2004) 1.02
Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report. Mov Disord (2005) 1.02
Mercury chloride decreases the water permeability of aquaporin-4-reconstituted proteoliposomes. Biol Cell (2008) 1.02
The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. Am J Hum Genet (2012) 1.02
Pramipexole-induced antecollis in Parkinson's disease. J Neurol Sci (2007) 1.01
Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol (2004) 1.01
Genome-wide association database developed in the Japanese Integrated Database Project. J Hum Genet (2009) 0.99
Primary motor cortical metaplasticity induced by priming over the supplementary motor area. J Physiol (2009) 0.99
Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate ends. Nucleic Acids Res (2007) 0.98
State-dependent and timing-dependent bidirectional associative plasticity in the human SMA-M1 network. J Neurosci (2011) 0.98